Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2011, Article ID 420981, 6 pages
http://dx.doi.org/10.4061/2011/420981
Review Article

CXCR4 and Axillary Lymph Nodes: Review of a Potential Biomarker for Breast Cancer Metastasis

1Division of Surgical Oncology, Department of Surgery, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA
2The Feist-Weiller Cancer Center, LSU Health Sciences Center, 1501 Kings Hwy, Shreveport, LA 71130, USA

Received 23 February 2011; Revised 23 May 2011; Accepted 2 July 2011

Academic Editor: Christoph Klein

Copyright © 2011 David Hiller and Quyen D. Chu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • Benoît Chénais, and Vincent Blanckaert, “The janus face of lipids in human breast cancer: how polyunsaturated Fatty acids affect tumor cell hallmarks.,” International journal of breast cancer, vol. 2012, pp. 712536, 2012. View at Publisher · View at Google Scholar
  • Santo Marsigliante, Carla Vetrugno, and Antonella Muscella, “CCL20 induces migration and proliferation on breast epithelial cells,” Journal Of Cellular Physiology, vol. 228, no. 9, pp. 1873–1883, 2013. View at Publisher · View at Google Scholar
  • Edwin A. Higuita, Fabian A. Jaimes, Maria T. Rugeles, and Carlos J. Montoya, “In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4,” Aids Research And Therapy, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Oya N. Sivrikoz, Latife Doganay, Ulas Kemal Sivrikoz, Serap Karaarslan, and Salahattin M. Sanal, “DISTRIBUTION OF CXCR4 AND gamma-CATENIN EXPRESSION PATTERN IN BREAST CANCER SUBTYPES AND THEIR RELATIONSHIP TO AXILLARY NODAL INVOLVEMENT,” Polish Journal of Pathology, vol. 64, no. 4, pp. 253–259, 2013. View at Publisher · View at Google Scholar
  • Soley Bayraktar, Angelica M. Gutierrez Barrera, Diane Liu, Lajos Pusztai, Jennifer Litton, Vicente Valero, Kelly Hunt, Gabriel N. Hortobagyi, Yun Wu, Fraser Symmans, and Banu Arun, “USP-11 as a Predictive and Prognostic Factor Following Neoadjuvant Therapy in Women With Breast Cancer,” Cancer Journal, vol. 19, no. 1, pp. 10–17, 2013. View at Publisher · View at Google Scholar
  • Polina Weitzenfeld, and Adit Ben-Baruch, “The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer,” Cancer Letters, vol. 352, no. 1, pp. 36–53, 2014. View at Publisher · View at Google Scholar
  • Heng Zeng, Wei Wei, and Xiaotao Xu, “Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer,” Oncology Letters, vol. 8, no. 1, pp. 77–81, 2014. View at Publisher · View at Google Scholar
  • Yue Li, Ying Wang, Suihai Wang, Yanjun Gao, Xuefeng Zhang, and Chunhua Lu, “Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells,” Medical Oncology, vol. 32, no. 1, 2014. View at Publisher · View at Google Scholar
  • María José Moreno, Rosa Bosch, Rebeca Dieguez-Gonzalez, Silvana Novelli, Ana Mozos, Alberto Gallardo, Miguel Ángel Pavón, María Virtudes Céspedes, Albert Grañena, Miguel Alcoceba, Oscar Blanco, Marcos Gonzalez-Díaz, Jorge Sierra, Ramon Mangues, and Isolda Casanova, “CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival,” The Journal of Pathology, 2014. View at Publisher · View at Google Scholar
  • Qi Liu, Xinzhao Wang, Minlin Lv, Dianbin Mu, Leilei Wang, Wensu Zuo, and Zhiyong Yu, “Effects of the ninein‑like protein centrosomal protein on breast cancer cell invasion and migration,” Molecular Medicine Reports, 2015. View at Publisher · View at Google Scholar
  • Changyuan Zhang, Jie Li, Yi Han, and Jian Jiang, “A meta-analysis for CXCRCR4 as a prognostic marker and potential drug target in non-small cell lung cancer,” Drug Design Development And Therapy, vol. 9, pp. 3267–3278, 2015. View at Publisher · View at Google Scholar
  • Xiao-Ming Zhou, Lan He, Gang Hou, Bing Jiang, Yuan-He Wang, and Li Zhao, “Clinicopathological significance of CXCR4 in non-small cell lung cancer.,” Drug design, development and therapy, vol. 9, pp. 1349–58, 2015. View at Publisher · View at Google Scholar
  • Antonella Muscella, Carla Vetrugno, and Santo Marsigliante, “CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture,” Molecular Carcinogenesis, 2017. View at Publisher · View at Google Scholar
  • Sonia Pernas, Miguel Martin, Peter A Kaufman, Marta Gil-Martin, Patricia Gomez Pardo, Sara Lopez-Tarruella, Luis Manso, Eva Ciruelos, Jose Alejandro Perez-Fidalgo, Cristina Hernando, Foluso O Ademuyiwa, Katherine Weilbaecher, Ingrid Mayer, Timothy J Pluard, Maria Martinez Garcia, Linda Vahdat, Jose Perez-Garcia, Achim Wach, Debra Barker, Samson Fung, Barbara Romagnoli, and Javier Cortes, “Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial,” The Lancet Oncology, 2018. View at Publisher · View at Google Scholar